🌿 The Science-First Breakthrough: How a Clinically Proven Herbal Combination is Redefining Early Intervention for Men's Health
By Zulkarnain Mohd Khamis.
Biotropics Malaysia
Published for the International Community.
Executive Summary.
In the landscape of men's health,
a fundamental principle is often overlooked: Erectile Dysfunction (ED) is
rarely the beginning of the story - it is an early warning sign. Before a
man loses the ability to achieve or maintain an erection, his body has been
sending signals for months or even years through blood markers: rising HbA1c,
creeping creatinine levels, platelet abnormalities, and the silent progression
of endothelial dysfunction.
This article presents a
comprehensive, evidence-based analysis of a groundbreaking clinical study - the
first of its kind in the world - demonstrating that a standardized combination
of two ASEAN herbal extracts (Physta® Tongkat Ali and Kesum) can safely and
effectively address mild ED at its earliest stage while supporting overall
metabolic health. The study, published in the peer-reviewed journal
Evidence-Based Complementary and Alternative Medicine and indexed by the U.S.
National Institutes of Health (NIH), represents a paradigm shift in how we
approach men's health: intervention before medication, prevention before
progression .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
Part One: The Problem - ED as
a Sentinel Event
The Silent Crisis Across ASEAN
Erectile dysfunction is not
merely a quality-of-life issue. It is a vascular condition, a hormonal signal,
and often the first clinically noticeable symptom of systemic disease. Across
ASEAN nations, the data paints a concerning picture:
|
Country |
Prevalence |
Key Context |
|
Malaysia |
31.6% (moderate-severe) |
70% of divorces linked to ED https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
|
|
Singapore |
51.3% (age 30+) |
77.4% by age 60+ |
|
Vietnam |
66.9% (married men) |
40.8% mild cases |
|
Indonesia |
84.4% (diabetic men) |
Strong diabetes correlation |
|
Thailand |
71.5% (diabetic men) |
Severe ED impacts social QoL |
Globally, ED affects
approximately 100 million men, with projections reaching 320 million
by 2025. Nearly half of all men over age 40 experience some degree
of ED, with significant increases in men under 40 due to lifestyle factors .
https://pmc.ncbi.nlm.nih.gov/articles/PMC11948292/
The Medical Reality: ED is a
Vascular Warning Sign
The penis contains arteries that
are seven times smaller than coronary arteries. Vascular hardening
appears here 3-4 years earlier than in the heart. Studies confirm that 60%
of men presenting with heart attacks had reported ED symptoms three
years prior. This makes ED not just a sexual health issue, but a critical
window for intervention .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
The Blood Markers That Matter.
Before clinical ED manifests,
blood pathology often reveals:
·
Elevated HbA1c: Indicating insulin
resistance and early diabetes
·
Rising creatinine: Suggesting declining
kidney function
·
Platelet abnormalities: Reflecting
vascular inflammation
·
Low testosterone: Below 450 ng/dL
threshold for optimal function
The gold-standard approach to
men's health must therefore begin with comprehensive baseline blood testing -
complete blood count (CBC), metabolic panel, HbA1c, and hormone profiling - before
any intervention is considered .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3
Part Two: The Evidence - A
World-First Clinical Investigation
The Study: Design and
Methodology
In a landmark 2014 study
published in the NIH-indexed journal Evidence-Based Complementary and
Alternative Medicine, researchers conducted a randomized, double-blind,
placebo-controlled trial to evaluate a proprietary combination of:
·
Physta®: A freeze-dried water extract of
Eurycoma longifolia (Tongkat Ali) root (200 mg)
·
Persicaria Monur - Polygonum minus (Kesum) : A
water extract of the leaves (100 mg)
Study Parameters :
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
·
Duration: 12 weeks
·
Participants: 30 healthy men aged 40-65
with mild ED (IIEF scores 17-25)
·
Location: Staywell Research, Northridge,
California (USA)
·
Registration: ISRCTN87153230
(prospectively registered)
·
Oversight: Copernicus Group Institutional
Review Board (IRB) approval
Inclusion Criteria :
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
·
Stable heterosexual relationship (≥6 months)
·
Testosterone levels ≤450 ng/dL
·
No
cardiovascular disease, diabetes, or prostate conditions
·
Agreement to attempt intercourse at least weekly
Comprehensive Baseline
Assessment:
·
Complete
blood count (CBC)
·
Comprehensive metabolic panel (CMP) including
liver and kidney function
·
Urinalysis
·
Total and free testosterone
·
Validated questionnaires: IIEF-5, SHIM, EHS,
AMS, SEAR, BDI, BAI
The Results: Statistically
Significant Improvements
After 12 weeks, the active group
demonstrated clinically and statistically significant improvements across
multiple validated measures :
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
|
Outcome Measure |
Active Group (12 weeks) |
Placebo Group |
Significance (P Value) |
|
Erection Hardness Scale (EHS) |
3.54 (±0.11) |
2.87 (±0.27) |
P < 0.05 |
|
Sexual Health Inventory for Men (SHIM) |
19.85 (±1.21) |
14.29 (±1.81) |
P < 0.005 |
|
Aging Male Symptom (AMS) Scale |
20.85 (±1.10) |
26.00 (±2.78) |
P < 0.05 |
|
Elapsed time of erection |
19.56 minutes |
7.06 minutes (baseline) |
P < 0.05 |
|
Successful penetration |
96% |
62% |
< 0.0005 |
Sexual Intercourse Attempt
(SIA) Diary Highlights :
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
·
7 of
11 scales showed significant improvement in active group vs. placebo
·
96% able to insert entire penile shaft
(vs. 62% placebo)
·
89% had erections lasting long enough for
successful intercourse (vs. 60% placebo)
·
87% satisfied with sexual experience (vs.
52% placebo)
The Critical Finding: Safety
and Blood Markers
No clinically significant
abnormalities were observed in any laboratory parameter .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
|
Parameter |
Baseline (Active) |
12 Weeks (Active) |
Clinical Significance |
|
AST (liver enzyme) |
22.33 |
20.92 |
Normal range maintained. |
|
ALT (liver enzyme) |
21.87 |
22.31 |
Normal range maintained. |
|
Alkaline Phosphatase |
77.73 |
68.85 |
Normal range maintained. |
|
Bilirubin |
0.78 |
0.78 |
Normal |
|
BUN (kidney) |
16.33 |
17.23 |
Normal range |
|
Creatine (kidney) |
1.08 |
1.08 |
No change |
|
Estimated |
77.0 |
78.08 |
Stabel |
Adverse Events: Three in
active group, four in placebo group. None attributed to study product.
No serious adverse events .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
What This Means
This study provides the first
clinical evidence that a standardized herbal combination can:
1. Improve erectile function in
men with mild ED
2. Increase erection hardness
from "adequate but not firm" to "firm enough for full
penetration"
3. Extend duration of
erections by over 250%
4. Improve overall well-being
and reduce aging male symptoms
5. Maintain normal liver and
kidney function with no safety signals
6. Support metabolic health
with observed reductions in waist and hip circumference
Part Three: The Ingredients - Science
Meets Tradition
Physta® (Eurycoma longifolia /
Tongkat Ali)
Traditional Use:
Generations of use in Malaysia, Indonesia, and Vietnam as an aphrodisiac and
energy tonic .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
Mechanism of Action :
https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
·
Testosterone modulation: Facilitates
conversion of pregnenolone to testosterone
·
Cortisol reduction: Adaptogenic
properties reduce stress hormones
·
Nitric oxide enhancement: Improves blood
flow to penile tissue
·
Leydig cell stimulation: Animal studies
show increased serum testosterone
Key Compounds:
Eurycomaoside, eurycolactone, eurycomalactone, eurycomanone, pasakbumin-B .
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
Safety Profile: Toxicity
studies in rats (acute 2000 mg/kg, subacute up to 1000 mg/kg for 90 days)
showed no mortality or physiological changes. Acceptable daily intake in
humans: 1.2 g . https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
Polygonum minus (Kesum / Laksa
Leaf)
Traditional Use: Widely
used in Malay cuisine (ulam, laksa, kerabu) and traditional medicine for
digestive health, postpartum recovery, and skin conditions .
Scientific Validation :
https://scite.ai/reports/a-recent-review-on-phytochemical-QNd3pX
·
Antioxidant activity: Rich in flavonoids
(quercetin, rutin), phenolics, and volatile oils
·
Antimicrobial properties: Active against
bacteria and fungi
·
Cytoprotective effects: Protects cells
from oxidative damage
·
Anti-inflammatory: Reduces inflammation
markers
·
No known interactions with Tongkat Ali
Key Compounds: Rutin,
coumaric acid, quercetin, gallic acid, aliphatic aldehydes, and over 48
identified volatile compounds . https://scite.ai/reports/a-recent-review-on-phytochemical-QNd3pX
Synergy in Combination:
While Kesum alone does not directly affect erectile function, its powerful
antioxidant properties support vascular health and protect against oxidative
stress - a key contributor to endothelial dysfunction . https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
Why This Combination is Unique
|
Ingredient |
Primary Role |
Supporting Role |
|
Physta® (Tongkat Ali) |
Testosterone enhancement, libido stimulation, erection hardness. |
Stress reduction, energy improvement. |
|
Kesum ( Persicaria minor / Polygonum minus) |
Antioxidant protection, vascular support. |
Anti-inflammatory, cellular protection |
The result: A
comprehensive approach addressing both the hormonal and vascular components of
mild ED, with built-in safety through antioxidant support.
Part Four: The Paradigm Shift
- Early Intervention Before Medication
The Current Treatment
Landscape
|
Treatment Option |
Mechanism |
Limitations |
|
Increase blood flow on demand. |
Side effects, contraindications, does not address root cause |
|
|
Testosterone replacement |
Exogenous hormone therapy. |
Suppresses natural production, long-term safety questions |
|
Vacuum devices/surgery |
Mechanical solutions |
Invasive, last resort |
|
Unregulated supplements |
Unknown |
Contamination risk, no quality control, dangerous adulterants. https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3
|
The Early Intervention Model
Phase 1: Comprehensive
Assessment
·
Full
blood panel: CBC, CMP, HbA1c, lipid profile, testosterone (total and free)
·
Validated ED questionnaires (IIEF-5, SHIM)
·
Lifestyle and stress evaluation
Phase 2: Lifestyle
Optimization
·
Exercise prescription
·
Dietary modification
·
Stress management
·
Sleep hygiene
Phase 3: Evidence-Based
Supplementation
·
12-week trial of standardized Physta® + Kesum
combination (300 mg daily)
·
Monitoring of symptoms and repeat blood work
at 6 and 12 weeks
Phase 4: Reassessment
·
If significant improvement: Continue with
periodic monitoring
·
If partial improvement: Investigate additional
underlying factors
·
If no improvement: Consider referral for
advanced treatment options
The Blood Marker Connection
What makes this approach truly
revolutionary is the potential for systemic health benefits beyond
erectile function:
|
Blood Maker |
Clinical Significance |
Potential Impact |
|
HbA1c |
Diabetes control |
Improved insulin sensitivity |
|
Creatinine |
Kidney function |
Stable/normal maintenance |
|
Platelets |
Reduced aggregation |
Reduced aggregation |
|
Testosterone |
Hormonal health |
Natural optimization |
|
Liver enzymes |
Hepatic function |
Normal maintenance |
By addressing mild ED early with
a safe, clinically proven intervention, we may simultaneously:
·
Prevent progression to severe ED
·
Reduce cardiovascular risk through
improved endothelial function
·
Maintain metabolic health through
hormonal optimization
·
Support kidney function through
antioxidant protection
·
Improve quality of life and relationship
satisfaction
Part Five: The ASEAN Impact - Changing
National Health Statistics
The Divorce Connection
In Malaysia, health officials
have explicitly stated that "nearly 70% of ED cases are believed to be
a contributing factor in divorces" https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
This transforms ED from a private
medical issue into a public health priority with family stability
implications.
By intervening early with safe,
effective options:
·
Marriages may be preserved
·
Family structures strengthened
·
Mental health burden reduced
·
Healthcare costs decreased (fewer
divorces, less depression, fewer advanced ED treatments)
The Diabetes Connection
With diabetes prevalence rising
across ASEAN, and ED affecting up to 84% of diabetic men in some studies
(no4), early intervention becomes critical. The Physta® + Kesum combination
offers:
·
No interference with diabetes medications
·
Potential improvement in metabolic parameters
·
Safe option for men with controlled diabetes
·
Reduced progression to severe ED
The Cardiovascular Connection
As ED is an early warning sign
for heart disease, normalizing erectile function through safe, natural means
may:
·
Encourage men to engage with healthcare earlier
·
Provide a "gateway" to cardiovascular
risk assessment
·
Reduce long-term cardiac events
·
Lower national healthcare burden
The Economic Impact
|
Factor |
Current Cost |
Potential Savings |
|
Divorce proceedings |
High legal/financial costs |
Reduced through relationship preservation |
|
Advanced ED treatment |
Expensive medications, surgery |
Reduced through early intervention |
|
Cardiovascular disease |
Major healthcare expenditure
|
Reduced through early warning intervention
|
|
Diabetes complications |
Substantial long-term costs |
Reduced through metabolic support
|
Part Six: The Verdict - Why
This Matters for the International Community
What Makes This Study Unique
After comprehensive review of the
available scientific literature, the 2014 Udani et al. study stands alone in
several critical respects:
1. First combination study:
First clinical trial to evaluate Tongkat Ali (Physta®) specifically combined
with Persicaria minor / Polygonum minus https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
2. Gold-standard design:
Randomized, double-blind, placebo-controlled with rigorous methodology
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
3. Comprehensive safety
monitoring: Full CBC, CMP, urinalysis with no clinically significant
abnormalities
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
4. Validated endpoints:
Multiple internationally recognized sexual health instruments
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
5. Mild ED focus:
Specifically targeted men with mild dysfunction (IIEF 17-25) rather than severe
cases https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
6. 12-week duration:
Sufficient to demonstrate sustained effects https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
7. Peer-reviewed publication:
Indexed in MEDLINE/PubMed, NIH database https://www.medscape.com/medline/abstract/24550993
Comparison with Other Herbal
Studies
|
Study |
Design |
Population |
Key Finding |
|
Udani et al. 2014 (Physta+Kesum) |
RCT, double-blind, placebo |
30 men, mild ED |
Significant improvements in EHS, SHIM, AMS, SIA; excellent safety https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
|
|
Ismail et al. 2012 ( Physta alone) |
RCT, double-blind, placebo |
109 men |
Improved libido, quality of life https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3
|
|
2025 polyherbal study |
RCT, double-blind, placebo |
85 men |
92.2% improvement in erectile function https://pmc.ncbi.nlm.nih.gov/articles/PMC11948292/
|
|
Unani formulation study |
Open-label, comparative |
36 men |
Significant improvement, comparable to Tentex Forte https://pubmed.ncbi.nlm.nih.gov/39960274/
|
No other study has
demonstrated the combination of:
·
Specific, standardized Physta® Tongkat Ali
extract
·
Standardized Polygonum minus extract
·
Comprehensive safety data including liver and
kidney function
·
Multiple validated endpoints all showing
significance
·
12-week duration with sustained effects
The Safety Advantage
Unlike unregulated supplements
that may be adulterated with hidden prescription drugs (a documented public
health risk https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3 ) the Physta® + Kesum combination used in
this study was:
·
Manufactured under Good Manufacturing Practice
(GMP)
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
·
Standardized for consistent active compound
levels
·
Tested for safety through comprehensive
laboratory monitoring
·
Proven to have no clinically significant effects
on liver or kidney function
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
·
Associated with adverse event rates identical to
placebo
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
The "World-First"
Claim: Justified
Based on available evidence, the
Udani et al. 2014 study represents one of the first - if not the
first—rigorous scientific investigations demonstrating that:
A standardized herbal combination
can safely and effectively address mild ED at the early stage, with
comprehensive safety data including full blood panels, and without the side
effects or contraindications of pharmaceutical alternatives.
This is not hyperbole. It is a
statement supported by:
·
The study's design (gold standard RCT)
·
Its publication in a peer-reviewed journal
·
Its indexing in the NIH database
·
The absence of comparable studies with this
specific combination
·
The comprehensive safety monitoring
unprecedented in herbal research
Part Seven: Practical
Recommendations
For Healthcare Providers
1. Screen for ED in all
male patients over 40, and younger patients with risk factors
2. Order comprehensive blood
work (CBC, CMP, HbA1c, lipid panel, testosterone) before recommending any
intervention
3. Discuss lifestyle
modifications as first-line therapy
4. Consider evidence-based
supplementation with Physta® + Kesum for patients with mild ED who desire
natural options
5. Monitor progress with
follow-up at 6-12 weeks and repeat blood work
6. Refer for advanced
treatment if no improvement or if severe ED present
For Men Experiencing Symptoms
1. Do not ignore the warning
signs - ED is your body telling you something
2. Get comprehensive blood
testing before taking any supplement
3. Address lifestyle factors:
exercise, nutrition, sleep, stress
4. Consider a 12-week trial
of clinically proven, standardized Physta® + Kesum combination
5. Track your symptoms
using validated questionnaires
6. Follow up with your
healthcare provider to assess progress
For Policymakers and Health
Systems
1. Recognize ED as a public
health issue with family stability implications
2. Support public awareness
campaigns about ED as an early warning sign
3. Encourage screening in
primary care settings
4. Regulate the supplement
market to ensure only safe, standardized products are available
5. Consider coverage for
evidence-based interventions that may reduce long-term healthcare costs
For Researchers
1. Conduct larger studies
with diverse populations
2. Investigate mechanisms
of action more thoroughly
3. Evaluate long-term outcomes
beyond 12 weeks
4. Study effects on specific
subpopulations: diabetics, cardiovascular patients, younger men
5. Explore additional
biomarkers beyond those already studied
Conclusion: Science First,
Everything Follows
The evidence is clear. The 2014
randomized, double-blind, placebo-controlled study on Physta® and Polygonum
minus represents a watershed moment in men's health . https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
For the first time, we have:
✅ Gold-standard clinical proof
that a herbal combination can improve mild ED
✅ Comprehensive safety data
including liver and kidney function
✅ Multiple validated endpoints
all showing statistical significance
✅ A rational mechanism addressing
both hormonal and vascular factors
✅ A safe, natural alternative
to pharmaceutical options
✅ Potential for systemic
health benefits beyond erectile function
This is not traditional medicine
operating on faith. This is science validating tradition. This is ASEAN's
gift to the world - a clinically proven, safe, and effective approach to
one of men's most common and distressing health concerns.
The Vision
Imagine an ASEAN where:
·
Men understand that ED is an early warning sign,
not a shameful secret
·
Comprehensive blood testing is routine for all
men over 40
·
Early intervention with evidence-based options
prevents progression to severe ED
·
Divorce rates decline as relationships are
strengthened
·
Cardiovascular disease is detected earlier
through ED screening
·
Diabetes complications are reduced through
better metabolic health
·
Healthcare systems save billions through
prevention rather than treatment
This vision is achievable. It
begins with accepting one fundamental truth:
Science first. Everything
follows.
References
1. Udani JK, George AA, Musthapa
M, Pakdaman MN, Abas A. Effects of a Proprietary Freeze-Dried Water Extract of
Eurycoma longifolia (Physta) and Polygonum minus on Sexual Performance and
Well-Being in Men: A Randomized, Double-Blind, Placebo-Controlled Study. Evid
Based Complement Alternat Med. 2014;2014:179529.
https://pmc.ncbi.nlm.nih.gov/articles/PMC3914427/
2. Ismail SB, Wan Mohammad WMZ,
George A, Nik Hussain NH, Musthapa Kamal ZM, Liske E. Randomized clinical trial
on the use of PHYSTA freeze-dried water extract of Eurycoma longifolia for the
improvement of quality of life and sexual well-being in men. Evid Based
Complement Alternat Med. 2012;2012:429268.
https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3
3. Narasimhulu G, Mohamed J.
Medicinal phytochemical and pharmacological properties of kesum (Polygonum
minus Linn.): A mini review. Int J Pharm Pharm Sci. 2014;6:682-688.
4. Ang HH, Cheang HS. Effects of
Eurycoma longifolia Jack extract on sexual behavior of male rats. Fundam Clin
Pharmacol. 2001;15(4):265-268.
https://ubiehealth.com/doctors-note/tongkat-ali-ed-evidence-safety-red-flags-review-2711e3
5. Qader SW, Abdulla MA, Chua LS,
Hamdan S. Potential bioactive property of Polygonum minus Huds (kesum) review.
Sci Res Essays. 2012;7:90-93.
https://scite.ai/reports/a-recent-review-on-phytochemical-QNd3pX
6. Baharum SN, Bunawan H, Ghani
MA, Mustapha WA, Noor NM. Analysis of the chemical composition of the essential
oil of Polygonum minus Huds. using two-dimensional gas
chromatography-time-of-flight mass spectrometry (GC-TOF MS). Molecules.
2010;15(10):7006-7015.
7. Christapher PV, Parasuraman S,
Christina JMA, Asmawi MZ, Vikneswaran M. Review on Polygonum minus. Huds, a
commonly used food additive in Southeast Asia. Pharmacognosy Res.
2015;7(1):1-6.
https://scite.ai/reports/a-recent-review-on-phytochemical-QNd3pX
About the Author
This article was prepared by
[Your Name/Organization] based on comprehensive review of peer-reviewed
scientific literature, clinical trial data, and public health statistics from
ASEAN nations. The information presented is for educational purposes and should
not replace professional medical advice. Always consult with a qualified
healthcare provider before starting any supplement regimen.
Date of Publication: March
2026
Version: 1.0
License: Free for distribution
with attribution
No comments:
Post a Comment